19 employees
Pentixapharm develop PentixaFor and PentixaTher as a theranostic radiopharmaceutical pair.
2019
$17M
from 1 investors over 1 rounds
PentixaPharm GmbH raised $17M on February 6, 2020
Investors: ELSA Eckert Life Science Accelerator GmbH